
CAS Number91421-42-0
Synonymsrubitecan; MFCD06656294; PYRIDOXINE 3,4-DIPALMITATE; 9-nitro-20(s)-camptothecin; (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Orathecin
Molecular FormulaC20H15N3O6
Molecular Weight393.35
Purity≥98 (HPLC)%
Density1.6±0.1 g/cm3
Boiling Point816.3±65.0 °C at 760 mmHg
Melting Point182-186 °C
Appearancepowder
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 91421-42-0 |
| Catalog No. | 2A-9012353 |
| Chinese Name | 9-硝基喜树碱 |
| Synonyms | rubitecan; MFCD06656294; PYRIDOXINE 3,4-DIPALMITATE; 9-nitro-20(s)-camptothecin; (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Orathecin |
| Molecular Formula | C20H15N3O6 |
| Molecular Weight | 393.35 |
| Purity | ≥98 (HPLC) |
| Density | 1.6±0.1 g/cm3 |
| Boiling Point | 816.3±65.0 °C at 760 mmHg |
| Melting Point | 182-186 °C |
| Appearance | powder |
| Storage Condition | Room temp |
| Application | Rubitecan (RFS 2000), a camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity that induces protein-linked DNA single-strand breaks, thereby blocking DNA |
| PubChem ID | 329824025 |
| MDL Number | MFCD06656294 |
| SMILES | CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(cccc5nc34)[N+]([O-])=O)C2=O |
| InChI | 1S/C20H15N3O6/c1-2-20(26)13-7-16-17-10(8-22(16)18(24)12(13)9-29-19(20)25)6-11-14(21-17)4-3-5-15(11)23(27)28/h3-7,26H,2,8-9H2,1H3/t20-/m0/s1 |
| InChI Key | VHXNKPBCCMUMSW-FQEVSTJZSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352204 |
| Hazard Symbols | Transport |
| MSDS | msds/12353_1_91421_42_0.pdf |
| Bioactivity | Rubitecan (RFS 2000), a camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3]. Related Catalog Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Topoisomerase Target Topoisomerase I[1] In Vitro Rubitecan (RFS 2000) inhibits U-CH1, U-CH2, and CCL4 cells with IC50s 0.32, 0.83, and 7.7 µM, respectively[4]. References [1]. Burris HA 3rd, et al. Phase II trial of oral rubitecan in previously treated pancreatic cancer patients. Oncologist. 2005 Mar;10(3):183-90. [2]. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000. Drugs R D. 2004;5(5):305-11. [3]. Rubitecan [4]. Xia M, et al. Identification of repurposed small molecule drugs for chordoma therapy. Cancer Biol Ther. 2013 Jul;14(7):638-47. Chemical & Physical Properties Density 1.6±0.1 g/cm3 Boiling Point 816.3±65.0 °C at 760 mmHg Melting Point 182-186ºC Molecular Formula C20H15N3O6 Molecular Weight 393.350 Flash Point 447.5±34.3 °C Exact Mass 393.096100 PSA 127.24000 LogP 1.38 Vapour Pressure 0.0±3.1 mmHg at 25°C Index of Refraction 1.762 InChIKey VHXNKPBCCMUMSW-FQEVSTJZSA-N SMILES CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1 Storage condition Room temp |
| Use of | Rubitecan (RFS 2000), a camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3]. Properties Articles27 Name 9-Nitrocamptothecin Synonym More Synonyms rubitecan Biological Activity Description Rubitecan (RFS 2000), a camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3]. Related Catalog Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Topoisomerase Topoisomerase I[1] References [1]. Burris HA 3rd, et al. Phase II trial of oral rubitecan in previously treated pancreatic cancer patients. Oncologist. 2005 Mar;10(3):183-90. [2]. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000. Drugs R D. 2004;5(5):305-11. [3]. Rubitecan [4]. Xia M, et al. Identification of repurposed small molecule drugs for chordoma therapy. Cancer Biol Ther. 2013 Jul;14(7):638-47. Chemical & Physical Properties Molecular Formula C20H15N3O6 Exact Mass 393.096100 PSA 127.24000 Index of Refraction 1.762 InChIKey VHXNKPBCCMUMSW-FQEVSTJZSA-N Storage condition Room temp |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Roridin A | 14729-29-4 | 2A-9012343 |
| Rottlerin | 82-08-6 | 2A-9012348 |
| Roxatidine | 78273-80-0 | 2A-9012349 |
| Roxatidine acetate | 78628-28-1 | 2A-9012350 |
| Roxolonium metilsulfate | 53862-80-9 | 2A-9012352 |
| Rubixanthin | 3763-55-1 | 2A-9012354 |
| Rubratoxinb | 21794-01-4 | 2A-9012355 |
| Rufloxacin | 101363-10-4 | 2A-9012356 |
| Rufloxacin hydrochloride | 106017-08-7 | 2A-9012357 |
| Rupatadine | 2A-303442 | 2A-9012358 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA